Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
MN Elshafei, A El‐Bardissy, A Khalil… - European journal of …, 2021 - Wiley Online Library
Background Colchicine was recently repurposed for the management of coronavirus
disease 2019 (COVID‐19). This rapid review and meta‐analysis aimed to assess …
disease 2019 (COVID‐19). This rapid review and meta‐analysis aimed to assess …
[HTML][HTML] The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
Objective Colchicine has been utilized safely in a variety of cardiovascular clinical
conditions. Among its potential mechanisms of action is the non-selective inhibition of …
conditions. Among its potential mechanisms of action is the non-selective inhibition of …
Colchicine and high-intensity rosuvastatin in the treatment of non-critically ill patients hospitalised with COVID-19: a randomised clinical trial
T Shah, M McCarthy, I Nasir, H Archer, E Ragheb… - BMJ open, 2023 - bmjopen.bmj.com
Objective To evaluate the effect of colchicine and high-intensity rosuvastatin in addition to
standard of care on the progression of COVID-19 disease in hospitalised patients. Design A …
standard of care on the progression of COVID-19 disease in hospitalised patients. Design A …
Effect of colchicine on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials
SH Lan, CK Hsu, CC Lai, SP Chang, LC Lu… - Annals of …, 2022 - Taylor & Francis
Aim This meta-analysis aimed to assess the usefulness of colchicine in patients with COVID-
19. Methods PubMed, Web of Science, Ovid MEDLINE, the Cochrane Library, Embase, and …
19. Methods PubMed, Web of Science, Ovid MEDLINE, the Cochrane Library, Embase, and …
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study
PC Pafundi, R Galiero, V Simeon, L Rinaldi… - PLoS …, 2021 - journals.plos.org
Introduction During COVID-19 pandemic, the use of several drugs has represented the
worldwide clinical practice. However, though the current increase of knowledge about the …
worldwide clinical practice. However, though the current increase of knowledge about the …
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
G Guaraldi, M Meschiari, A Cozzi-Lepri… - The Lancet …, 2020 - thelancet.com
Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to
assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …
assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …
Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the …
Importance Severe acute respiratory syndrome coronavirus 2 infection has evolved into a
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial
C Perricone, M Scarsi, A Brucato, P Pisano… - European Journal of …, 2023 - Elsevier
Objective To evaluate whether the addition of colchicine to standard of care (SOC) results in
better outcomes in hospitalized patients with COVID-19. Design This interventional …
better outcomes in hospitalized patients with COVID-19. Design This interventional …
[HTML][HTML] Anticoagulant or antiplatelet use and severe COVID-19 disease: a propensity score-matched territory-wide study
To the Editor: We read the recent publication in Pharmacological Research on the impact of
pre-admission antithrombotic therapy in coronavirus disease 2019 (COVID-19) patients with …
pre-admission antithrombotic therapy in coronavirus disease 2019 (COVID-19) patients with …
[HTML][HTML] Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group - The Lancet Respiratory Medicine, 2021 - Elsevier
Background Colchicine has been proposed as a treatment for COVID-19 based on its anti-
inflammatory actions. We aimed to evaluate the efficacy and safety of colchicine in patients …
inflammatory actions. We aimed to evaluate the efficacy and safety of colchicine in patients …